Barrington Research Reinstates Outperform on Cinemark Hldgs, Maintains $24 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst James Goss reinstates Cinemark Holdings (CNK) with an Outperform rating and maintains a $24 price target.

May 06, 2024 | 2:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cinemark Holdings reinstated with an Outperform rating and a $24 price target by Barrington Research.
The reinstatement of Cinemark Holdings by Barrington Research with an Outperform rating and a maintained price target of $24 suggests a positive outlook on the company's stock. This endorsement by a reputable analyst could lead to increased investor confidence and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100